American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARA | DGX | DVA | CHE | EHC |
| Company | American Renal Associates | Quest Diagnostics Inc | Davita Healthcare Partners Inc | Chemed Inc | Encompass Health Corp |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 11.48 | 137.42 | 141.37 | 569.37 | 83.22 |
| High | 11.52 | 137.42 | 143.23 | 569.37 | 83.72 |
| Low | 11.33 | 135.35 | 139.72 | 558.77 | 82.38 |
| Last | 11.52 | 136.34 | 142.24 | 559.65 | 83.42 |
| Change | +0.02 | -1.21 | +2.49 | -6.45 | +0.54 |
| % Change | +0.17% | -0.88% | +1.78% | -1.14% | +0.65% |
| Volume | 9,800 | 695,100 | 1,893,500 | 91,300 | 465,400 |
| 20-Day Average Volume | 110,105 | 1,062,645 | 628,540 | 83,770 | 715,985 |
| Previous Close | 11.50 | 137.55 | 139.75 | 566.10 | 82.88 |
| Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 11.47 | 132.33 | 133.06 | 599.85 | 81.68 |
| 20-Day Raw Stochastic | 100.00% | 64.08% | 94.37% | 2.34% | 66.89% |
| 20-Day Relative Strength | 70.89% | 57.47% | 67.24% | 31.30% | 62.09% |
| Weighted Alpha | -7.72 | +2.35 | +69.49 | 0.00 | +38.23 |
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | 24% Sell | 100% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 88% Buy | 24% Sell | 100% Buy |
| Last Month's Opinion | 72% Buy | 24% Buy | 88% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.44% since 01/15/21 | +0.68% since 04/25/24 | +7.13% since 04/25/24 | -2.39% since 04/25/24 | +0.83% since 04/25/24 |
| Low | 11.33 on 01/25/21 | 134.05 on 04/26/24 | 130.96 on 04/26/24 | 557.90 on 04/26/24 | 82.09 on 04/26/24 |
| High | 11.52 on 01/25/21 | 142.46 on 04/29/24 | 143.23 on 05/02/24 | 577.17 on 04/26/24 | 84.07 on 05/01/24 |
| 1-Month | |||||
| %Chg | +0.70% since 12/24/20 | +3.06% since 04/02/24 | +5.33% since 04/02/24 | -12.12% since 04/02/24 | +1.73% since 04/02/24 |
| Low | 11.33 on 01/25/21 | 125.42 on 04/18/24 | 125.64 on 04/18/24 | 557.90 on 04/26/24 | 78.53 on 04/18/24 |
| High | 11.52 on 01/25/21 | 142.46 on 04/29/24 | 143.23 on 05/02/24 | 639.61 on 04/04/24 | 85.84 on 04/25/24 |
| 3-Month | |||||
| %Chg | +0.17% since 10/23/20 | +9.07% since 02/02/24 | +27.90% since 02/02/24 | -6.89% since 02/02/24 | +15.41% since 02/02/24 |
| Low | 11.33 on 01/25/21 | 123.18 on 02/05/24 | 108.76 on 02/12/24 | 557.90 on 04/26/24 | 70.83 on 02/05/24 |
| High | 11.52 on 01/25/21 | 142.46 on 04/29/24 | 143.23 on 05/02/24 | 654.62 on 03/15/24 | 85.84 on 04/25/24 |
| 6-Month | |||||
| %Chg | +80.56% since 07/24/20 | +3.81% since 11/02/23 | +82.80% since 11/02/23 | -3.37% since 11/02/23 | +31.87% since 11/02/23 |
| Low | 6.08 on 09/21/20 | 123.04 on 02/01/24 | 78.05 on 11/07/23 | 557.90 on 04/26/24 | 62.58 on 11/10/23 |
| High | 11.98 on 10/06/20 | 143.63 on 01/02/24 | 143.23 on 05/02/24 | 654.62 on 03/15/24 | 85.84 on 04/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 397,935 | 15,280,705 | 12,256,074 | 8,570,182 | 8,299,603 |
| Shares Outstanding, K | 34,543 | 111,092 | 87,700 | 15,139 | 100,140 |
| Annual Sales | 822,520,000 | 9,252,000,000 | 12,140,150,000 | 2,264,420,000 | 4,801,200,000 |
| Annual Net Income | -13,790,000 | 854,000,000 | 691,540,000 | 272,510,000 | 352,000,000 |
| Last Quarter Sales | 209,690,000 | 2,366,000,000 | 3,145,750,000 | 589,230,000 | 1,316,000,000 |
| Last Quarter Net Income | -2,690,000 | 194,000,000 | 150,670,000 | 65,020,000 | 112,500,000 |
| 60-Month Beta | 1.11 | 0.88 | 1.04 | 0.46 | 0.92 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.04 on 04/23/24 | 1.87 on 02/13/24 | 5.20 on 04/24/24 | 1.12 on 04/24/24 |
| Latest Earnings Date | 03/15/21 | 04/23/24 | 05/02/24 | 04/24/24 | 04/24/24 |
| Most Recent Dividend | N/A | 0.710 on 01/16/24 | N/A | 0.400 on 02/23/24 | 0.150 on 03/28/24 |
| Next Ex-Dividends Date | N/A | 01/16/24 | N/A | 02/23/24 | 03/28/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.86 | 16.59 | 26.65 | 21.49 |